Sue MacLeman has more than 30 years of experience as a pharmaceutical, biotechnology and medical technology executive who held senior roles in corporate, medical, commercial and business development.
She was the chief executive and board member of several ASX- and NASDAQ-listed companies in the pharmaceutical sector, and was appointed to several academic and government advisory committees.